US Patent Issued on April 14 for "Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain fatty acid or prodrug thereof" (German Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,648, issued on April 14.

"Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain fatty acid or prodrug thereof" was invented by Soren Ocvirk (Kranzberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition includes a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain C2 to C5 fatty acid and/or a salt and/or a prodrug thereof in a therapeutically effective amount and one or more pharmaceutically acceptable excipients as well as to a method of preventing and/or treating colorectal tumorigenesis and/or carcinogenesis and/or chronic intestinal i...